- Home
- EVTV vs INDP Comparison
EVTV vs INDP Comparison
Compare EVTV & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTV
- INDP
- Stock Information
- Founded
- EVTV 2012
- INDP 2000
- Country
- EVTV United States
- INDP United States
- Employees
- EVTV N/A
- INDP N/A
- Industry
- EVTV Auto Manufacturing
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- EVTV Consumer Discretionary
- INDP Health Care
- Exchange
- EVTV Nasdaq
- INDP Nasdaq
- Market Cap
- EVTV 6.2M
- INDP 6.0M
- IPO Year
- EVTV 2017
- INDP N/A
- Fundamental
- Price
- EVTV $4.08
- INDP $2.58
- Analyst Decision
- EVTV
- INDP Strong Buy
- Analyst Count
- EVTV 0
- INDP 2
- Target Price
- EVTV N/A
- INDP $238.00
- AVG Volume (30 Days)
- EVTV 114.3K
- INDP 96.3K
- Earning Date
- EVTV 08-18-2025
- INDP 11-11-2025
- Dividend Yield
- EVTV N/A
- INDP N/A
- EPS Growth
- EVTV N/A
- INDP N/A
- EPS
- EVTV N/A
- INDP N/A
- Revenue
- EVTV $1,884,395.00
- INDP N/A
- Revenue This Year
- EVTV N/A
- INDP N/A
- Revenue Next Year
- EVTV N/A
- INDP N/A
- P/E Ratio
- EVTV N/A
- INDP N/A
- Revenue Growth
- EVTV 2.97
- INDP N/A
- 52 Week Low
- EVTV $1.50
- INDP $2.34
- 52 Week High
- EVTV $21.30
- INDP $58.24
- Technical
- Relative Strength Index (RSI)
- EVTV 85.34
- INDP 21.26
- Support Level
- EVTV $2.02
- INDP $2.34
- Resistance Level
- EVTV $2.53
- INDP $2.86
- Average True Range (ATR)
- EVTV 0.30
- INDP 0.71
- MACD
- EVTV 0.13
- INDP -0.27
- Stochastic Oscillator
- EVTV 86.19
- INDP 4.70
About EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.